Sunshine Biopharma (SBFMW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 99 132 sessions, September 10, 2025 to August 31, 2026
- Largest daily move
- +123.6% close of June 23, 2026
- 1-year change
- -79.6% adjusted closes, September 10, 2025 to August 31, 2026
Company Description
Sunshine Biopharma (NASDAQ: SBFMW) is classified in the Pharmaceutical Preparations sector.
SBFMW has declined 80.1% over the past year. Shares last traded at $0.0310.
For FY2025, Sunshine Biopharma reported revenue of $36.3M with net income of -$6.0M. The company operates at a net profit margin of -16.5%.
This page collects what Stock Titan holds for SBFMW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sunshine Biopharma (SBFMW) stock last closed at $0.0310. Over the past 12 months, the stock has lost 80.1%.
SBFMW Rankings
Latest News
Sunshine Biopharma has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, private placement, covid-19, buybacks. View all SBFMW news →
SEC Filings
Sunshine Biopharma has filed 5 recent SEC filings, including 2 Form SCHEDULE 13G/A, 1 Form S-1, 1 Form 8-K, 1 Form 10-Q. The most recent filing was submitted on August 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SBFMW SEC filings →
Financial Highlights
Sunshine Biopharma generated $36.3M in revenue in FY2025, retaining a 33.8% gross margin, operating income reached -$6.2M (-17.2% operating margin), and net income was -$6.0M, reflecting a -16.5% net profit margin. The company generated -$5.3M in operating cash flow. With a current ratio of 4.17, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Sunshine Biopharma (SBFMW) currently stands at 773 shares, down 85.7% from the previous reporting period. Since September 2025, short interest has decreased by 44.8%.
Days to Cover History
Days to cover for Sunshine Biopharma (SBFMW) currently stands at 4.1 days, up 307% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
SBFMW Company Profile & Sector Positioning
Sunshine Biopharma (SBFMW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.
Investors comparing SBFMW often look at related companies in the same sector, including Biofrontera (BFRIW), Clever Leaves Holdings Inc (CLVRW), Sunshine Biopharma Inc (SBFM), Inmed Pharmaceuticals Inc (INM), and Aytu Biopharma Inc (AYTU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SBFMW's relative position within its industry.